ABILITY Neurotech Receives IMDD Approval for Chronic BCI Implantation in ALS Patients

Why it matters

ABILITY Neurotech's IMDD approval for a chronic BCI implant demonstrates that multiple regulatory jurisdictions are now developing frameworks for long-term neural device approval. International approvals de-risk the global commercialisation pathway for the broader implantable BCI field.